// App-Quantinova.ai

5337 : Tolinapant (ASTX660 enhances the anti-leukemic activity of Venetoclax and Dexamethasone in T cell acute lymphoblastic leukemia (T-ALL

Researchers

Presenter

  • Priyanka Sharma

Principal Investigators

  • Sujan Piya

  • Huaxian Ma

  • Natalia Baran

  • Muharrem Muftuoglu

  • Mahesh Basyal

  • Vivian Ruvolo

  • George Ward

  • Tomoko Smyth

  • Martin J. Sims

  • Michael Andreeff

  • Gautam Borthakur

Medical Centers

  • 1.MD Anderson Cancer Center, Houston, TX

  • Astex Pharmaceutical, Inc., Cambridge, United Kingdom.

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • T-cell lymphoma

  • Lymphomas

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • X-linked inhibitor of apoptosis

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Venetoclax

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I/II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved